Karim F. Damji

Karim F. Damji

Auto-generated profile, based on publicly available information

Karim F. Damji

University of Ottawa Eye Institute, Ottawa, Ontario, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2006 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
KDK F Damji
K F Damji
ABA M Bovell
A M Bovell
WHW G Hodge
W G Hodge
WRW Rock
W Rock
KSK Shah
K Shah
YPY I Pan
Y I Pan
Aims: To compare selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), in terms of intraocular pressure (IOP) lowering, in patients with open-angle glaucoma. Methods: 176 eyes of 152 patients were enrolled in this study, 89 in the SLT and 87 in the ALT groups. Patients were randomised to receive either SLT or ALT treatment to 180° of the trabecular meshwork. Patients were followed up to 12 months after treatment. The main outcome measured was IOP lowering at 12 months after treatment, compared between the SLT and ALT groups. Results: No significant difference (p = 0.846) was found in mean decrease in IOP between the SLT (5.86 mm Hg) and ALT (6.04 mm Hg) groups at 1 year or at any other time points, nor were there any significant differences in the rate of early or late complications between the two groups. Conclusions: SLT is equivalent to ALT in terms of IOP lowering at 1 year, and is a safe and effective procedure for patients with open-angle glaucoma.

13 April 2006 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
KDK F Damji
K F Damji
AKA G P Konstas
A G P Konstas
JLJ M Liebmann
J M Liebmann
WHW G Hodge
W G Hodge
NZN G Ziakas
N G Ziakas
RRR Ritch
R Ritch
To determine the long term intraocular pressure (IOP) response to phacoemulsification in patients with and without exfoliation syndrome (XFS). Prospective, multicentre, cohort study with the following inclusion criteria: age over 50 years, open iridocorneal angle, and cataract. Two groups were enrolled: those with XFS and those without. The main outcome was mean IOP reduction 2 years after phacoemulsification cataract extraction (PCE). Univariate and multivariate analyses were performed. 183 patients were enrolled, 71 with and 112 without XFS. There were 29 patients with glaucoma in both groups. Mean baseline IOP was higher in XFS compared to control eyes (17.60 (SD 3.23) mm Hg v 16.08 (3.18) mm Hg, p = 0.002). Overall IOP reduction was significantly greater in the XFS group at the 2 year time point (-1.85 mm Hg v -0.62 mm Hg in the controls (p = 0.0037)). Multivariate analysis demonstrated that the IOP lowering effect in the XFS group may be related to irrigation volume at the time of surgery. In the subgroup analyses IOP lowering was significantly greater in the XFS and XFG patients than in controls without glaucoma, and POAG controls, respectively. The percentage of patients with a postoperative IOP spike was similar and relatively high in both XFS and control groups (34% v 25%; p = 0.54). IOP decreases more in patients with XFS following PCE compared to control eyes without XFS. This effect is more pronounced in glaucoma patients and persists for at least 2 years.

1 April 2003 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
KDKarim F. Damji
Karim F. Damji
RBRama Behki
Rama Behki
LWLan Wang
Lan Wang

1 January 2005 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
OJO Jonsson
O Jonsson
KDK F Damji
K F Damji
FJF Jonasson
F Jonasson
AAA Arnarsson
A Arnarsson
TEThor Eysteinsson
Thor Eysteinsson
KSK Sasaki
K Sasaki
Aim: To establish the epidemiology of the grey crescent in a white population within the age range most susceptible to glaucoma. Methods: Bruce Shields was first to use this term to describe a localised, physiological pigmentation of the optic nerve neuroretinal rim tissue that is distinct from peripapillary pigmentation. An experienced glaucomatologist (KFD) evaluated stereofundus photographs of the participants of the Reykjavik Eye Study (RES)—a random sample from the national population census including people 50 years and older. 1012 right eyes could be evaluated for grey crescent. Results: The prevalence of grey crescent in the right eyes was 22.0% (95% CI 10 to 25). It was more commonly found in women (27.0%: 95% CI 23 to 30) than in men (17.0%: 95% CI 14 to 21), and was most often located temporally (36.9%), 360° (15.9%), or nasally (15.4%). The spherical equivalent was +1.30 dioptres (D) for those with and +0.80 D for those without grey crescent (p = 0.002), respectively. Vertical optic disc diameters were 0.203 v 0.195 units (p<0.001). There was no difference in the prevalence of grey crescent in glaucomatous or non-glaucomatous eyes (OR = 1.05, 95% CI 0.49 to 2.26). The prevalence of a grey crescent was inversely related to the prevalence of peripapillary atrophy (p = 0.001). Conclusions: The grey crescent needs to be recognised as a physiological variant in order to avoid falsely labelling eyes as having glaucomatous optic nerve damage.

1 September 2005
Verified
Journal Article
Closed access
FAFeisal A Adatia
Feisal A Adatia
KDKarim F Damji
Karim F Damji

1 February 2007 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
RBRama Behki
Rama Behki
KDKarim F. Damji
Karim F. Damji
ACAndrew Crichton
Andrew Crichton